Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

IL-17 receptor's "B team" may be pancreatic cancer target

March 9, 2021

Bayer and DKFZ patent AhR antagonists

March 9, 2021

Chinese investigators identify new TGFBR1 inhibitors

March 9, 2021

Artios Pharma divulges POLQ inhibitors

March 9, 2021

Idorsia Pharmaceuticals patents LGALS3 inhibitors

March 9, 2021

Collagen means well in pancreatic cancer

March 9, 2021

Chimerix opens enrollment in phase III study of dociparstat for AML

March 9, 2021

Incyte discloses CDK2/cyclin E inhibitors

March 8, 2021

BiSiChem identifies RIPK1 inhibitors

March 8, 2021

Taiho begins phase II study of TAS-117 in advanced solid tumors with germline PTEN mutations

March 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...